LLY 241220 685.00C (LLY241220C685000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

LLY241220C685000

Watchlist

53.30
0.000.00%

15min DelayClose Nov 18 13:35 ET

0.00High0.00Low

Intraday

5D
Daily

News

Insurer Stocks Tumble. Trump Echoes Drug Industry Attacks on PBMs. -- Barrons.com
Barron's14:03 ET
Moderna Remains the Most Shorted Among S&P 500 Healthcare Stocks in November
Seeking Alpha13:05 ET
Express News | Trump: 'We're Going to Knock Out the Middlemen' Who Are Keeping Drug Prices High
Reuters11:47 ET
Express News | Trump: Does Not Like Mandates for Vaccines, When Asked Whether Schools Should Mandate
Reuters11:46 ET
Express News | Trump: I'm a Big Believer in Polio Vaccine
Reuters11:46 ET
Another Week, Another Index Record | Lkive Stock
Kevin TraversDec 16 10:42 ET

Comments

10xStockPicks

20 hours ago

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...